(Adds expert comment from meeting, New Zealand case, background) Aug 30 (Reuters) – An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Monday unanimously recommended the Pfizer Inc and BioNTech Se COVID-19 vaccine for people age 16 and older, an important step after it gained full U.S. approval. The Food and Drug Administration last week granted full approval to the vaccine that was previously available under the agency’s emergency use authorization (EUA), which… Source link
Read More »UPDATE 3-U.S. CDC advisers vote in favor of Pfizer/BioNTech vaccine after full approval
